SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001038133-21-000011
Filing Date
2021-02-26
Accepted
2021-02-26 10:30:41
Documents
111
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K hska-20201231.htm   iXBRL 10-K 2967499
2 EX-4.2 heska-12312020xex42.htm EX-4.2 19417
3 EX-10.15 heska-12312020xex1015.htm EX-10.15 27358
4 EX-10.30 heska-12312020xexx1030.htm EX-10.30 76343
5 EX-10.31 heska-12312020xex10x31.htm EX-10.31 99689
6 EX-10.32 heska-12312020xex1032.htm EX-10.32 93520
7 EX-21.1 heska-12312020xex211.htm EX-21.1 5746
8 EX-23.1 heska-12312020xex231.htm EX-23.1 2650
9 EX-23.2 heska-12312020xex232.htm EX-23.2 2883
10 EX-31.1 heska-12312020xex31x1.htm EX-31.1 11188
11 EX-31.2 heska-12312020xexx31x2.htm EX-31.2 10968
12 EX-32.1 heska-12312020xexx32x1.htm EX-32.1 9519
18 LOGO hska-20201231_g1.jpg GRAPHIC 53004
19 CHART hska-20201231_g2.jpg GRAPHIC 134190
  Complete submission text file 0001038133-21-000011.txt   15092167

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20201231.xsd EX-101.SCH 79346
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hska-20201231_cal.xml EX-101.CAL 194386
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hska-20201231_def.xml EX-101.DEF 552607
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20201231_lab.xml EX-101.LAB 1138758
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20201231_pre.xml EX-101.PRE 785452
20 EXTRACTED XBRL INSTANCE DOCUMENT hska-20201231_htm.xml XML 2645254
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22427 | Film No.: 21684819
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences